Cholinesterase

2 papers1 finding

Human trial1
Model organisms1

Interventions

1

Adipose-derived mesenchymal stem cells

downin humans1

1 study

Adipose-derived mesenchymal stem cells decrease cholinesterase in humans (mean difference: -21.905 U/L, p < 0.001).
“A paired samples t‐test revealed a statistically significant decrease in cholinesterase levels after ADSC administration (mean difference: ‐21.905 U/L, p < 0.001).”
Human trialserumn = 21
Immediate Effects of Adipose‐Derived Mesenchymal Stem Cell Administration on Cholinesterase Levels and Grip Strength
AAIC 2025 abstract25 Dec 2025

More on Adipose-derived mesenchymal stem cells

Latest

6 in 12 months

Behavioural Brain Research28 Sep

Aging reduces basal cholinergic reserve, but the pattern of scopolamine-induced memory impairment remains comparable in rats

Experiments in ratsMechanisms

Journal of Neurology, Neurosurgery, and Psychiatry24 Aug

Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing

Cohort study of 113 peopleAlzheimer's disease

3 Biotech8 Jan

Neuropharmacology of synaptic plasticity: pathways to cognitive resilience in healthy aging

AAIC 2025 Abstract26 Dec

Immediate Effects of Adipose‐Derived Mesenchymal Stem Cell Administration on Cholinesterase Levels and Grip Strength

Non-randomised trial in 21 peopleInterventions

Biogerontology24 Dec

Synergistic effects of 3-O-methylquercetin and polyphenols on longevity, healthspan, and neuroprotection via FOXO/Nrf2

Experiments in wormsInterventions

Journal of Applied Physiology14 Nov

Donepezil treatment, alone or combined with exercise, enhances skeletal muscle function in healthy and advanced aging disease mouse models

Experiments in 12 miceExercise